Your browser doesn't support javascript.
loading
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor.
Wang, Wenxian; Wang, Qian; Xu, Chunwei; Li, Ziming; Song, Zhengbo; Zhang, Yongchang; Cai, Xiuyu; Zhang, Shirong; Lian, Bin; Li, Wen; Liu, Anwen; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Chen, Yu; Yuan, Jingping; Wang, Feng; Jiang, Zhansheng; Lin, Gen; Pu, Xingxiang; Rao, Chuangzhou; Lv, Dongqing; Yu, Zongyang; Li, Xiaoyan; Tang, Chuanhao; Zhou, Chengzhi; Xie, Congying; Zhang, Junping; Guo, Hui; Chu, Qian; Meng, Rui; Wu, Jingxun; Zhang, Rui; Wang, Liping; Zhu, Youcai; Hu, Xiao; Xie, Yanru; Lin, Xinqing; Cai, Jing; Lan, Fen; Feng, Huijing; Wang, Lin; Yao, Wang; Shi, Xuefei; Huang, Jianhui; Chen, Huafei; Zhang, Yinbin; Sun, Pingli.
Afiliação
  • Wang W; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.
  • Wang Q; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
  • Xu C; Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, China.
  • Li Z; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Song Z; Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Zhang Y; Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou, China.
  • Cai X; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Zhang S; Department of VIP Inpatient, Sun Yet-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Lian B; Translational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, China.
  • Li W; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital and Institute, Beijing, China.
  • Liu A; Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China.
  • Zhan P; Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Liu H; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Lv T; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Miao L; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Min L; Department of Respiratory Medicine, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
  • Chen Y; Department of Respiratory Medicine, Clinical Medical School of Yangzhou University, Subei People's Hospital of Jiangsu Province, Yangzhou, China.
  • Yuan J; Department of Medical Oncology, Fujian Medical University Cancer Hospital and Fujian Cancer Hospital, Fuzhou, China.
  • Wang F; Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Jiang Z; Department of Internal Medicine, Cancer Center of PLA, Qinhuai Medical Area, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Lin G; Derpartment of Integrative Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Pu X; Department of Medical Oncology, Fujian Medical University Cancer Hospital and Fujian Cancer Hospital, Fuzhou, China.
  • Rao C; Department of Medical Oncology, Lung Cancer, and Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Lv D; Department of Radiotherapy and Chemotherapy, Hwamei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
  • Yu Z; Department of Pulmonary Medicine, Taizhou Hospital of Wenzhou Medical University, Taizhou, China.
  • Li X; Department of Respiratory Medicine, The 900th Hospital of the Joint Logistics Team (The Former Fuzhou General Hospital), Fujian Medical University, Fuzhou, China.
  • Tang C; Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Zhou C; Department of Medical Oncology, Peking University International Hospital, Beijing, China.
  • Xie C; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University (The First Affiliated Hospital of Guangzhou Medical University), Guangzhou, China.
  • Zhang J; Department of Radiation Oncology, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
  • Guo H; Department of Thoracic Oncology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, China.
  • Chu Q; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Meng R; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wu J; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhang R; Department of Medical Oncology, The First Affiliated Hospital of Medicine, Xiamen University, Xiamen, China.
  • Wang L; Department of Medical Oncology, Cancer Hospital of China Medical University, Shenyang, China.
  • Zhu Y; Department of Oncology, Baotou Cancer Hospital, Baotou, China.
  • Hu X; Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, China.
  • Xie Y; Zhejiang Key Laboratory of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
  • Lin X; Department of Oncology, Lishui Municipal Central Hospital, Lishui, China.
  • Cai J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University (The First Affiliated Hospital of Guangzhou Medical University), Guangzhou, China.
  • Lan F; Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Feng H; Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China.
  • Wang L; Department of Thoracic Oncology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, China.
  • Yao W; Department of Pathology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, China.
  • Shi X; Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Huang J; Department of Respiratory Medicine, Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, China.
  • Chen H; Department of Oncology, Lishui Municipal Central Hospital, Lishui, China.
  • Zhang Y; Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, China.
  • Sun P; Department of Oncology, The Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, China.
Thorac Cancer ; 13(23): 3420-3430, 2022 12.
Article em En | MEDLINE | ID: mdl-36268845
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pneumonia / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Guideline / Qualitative_research / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Thorac Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pneumonia / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Guideline / Qualitative_research / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Thorac Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China